Salix

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 4 drugs with upcoming expirations

Activity

Key Events

Feb 9, 2024FDAPulmicort — EOHILIA

Feb 9, 2024FDAUceris — EOHILIA

Dec 15, 2021FDAPulmicort — TARPEYO

Dec 15, 2021FDAUceris — TARPEYO

Jun 13, 2019FDAPulmicort — ORTIKOS

Jun 13, 2019FDAUceris — ORTIKOS

Jan 19, 2017FDATrulance — TRULANCE

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

18 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Xifaxan4 patentsFeb 27, 2026 Pulmicort6 patentsNov 9, 2026 RelistorAug 3, 2027 XifaxanSep 2, 2027 TrulanceJan 30, 2028 Pulmicort2 patentsNov 12, 2028 Xifaxan15 patentsFeb 26, 2029 Pulmicort3 patentsMay 7, 2029

10 more

Relistor5 patentsSep 30, 2029 RelistorDec 31, 2030 Relistor5 patentsMar 10, 2031 Pulmicort5 patentsSep 7, 2031 Trulance3 patentsSep 15, 2031 Trulance2 patentsMar 1, 2032 Trulance4 patentsJun 5, 2034 Pulmicort2 patentsSep 9, 2036 Pulmicort2 patentsJan 10, 2039 Pulmicort4 patentsJan 23, 2043

Regulatory

Regulatory Timeline

20012 events

FDAOct 2

Pulmicort — ENTOCORT EC

Application NDA021324 (NDA)

FDAOct 2

Uceris — ENTOCORT EC

Application NDA021324 (NDA)

20041 event

FDAMay 25

Xifaxan — XIFAXAN

Application NDA021361 (NDA)

20062 events

FDAJul 12

Pulmicort — PULMICORT FLEXHALER

Application NDA021949 (NDA)

FDAJul 12

Uceris — PULMICORT FLEXHALER

Application NDA021949 (NDA)

20101 event

FDASep 27

Relistor — RELISTOR

Application NDA021964 (NDA)

20132 events

FDAJan 14

Pulmicort — UCERIS

Application NDA203634 (NDA)

FDAJan 14

Uceris — UCERIS

Application NDA203634 (NDA)

20142 events

FDAOct 7

Pulmicort — UCERIS

Application NDA205613 (NDA)

FDAOct 7

Uceris — UCERIS

Application NDA205613 (NDA)

20152 events

FDAMar 23

Pulmicort — RHINOCORT ALLERGY

Application NDA020746 (NDA)

FDAMar 23

Uceris — RHINOCORT ALLERGY

Application NDA020746 (NDA)

20161 event

FDAJul 19

Relistor — RELISTOR

Application NDA208271 (NDA)

20171 event

FDAJan 19

Trulance — TRULANCE

Application NDA208745 (NDA)

20192 events

FDAJun 13

Pulmicort — ORTIKOS

Application NDA211929 (NDA)

FDAJun 13

Uceris — ORTIKOS

Application NDA211929 (NDA)

20212 events

FDADec 15

Pulmicort — TARPEYO

Application NDA215935 (NDA)

FDADec 15

Uceris — TARPEYO

Application NDA215935 (NDA)

20242 events

FDAFeb 9

Pulmicort — EOHILIA

Application NDA213976 (NDA)

FDAFeb 9

Uceris — EOHILIA

Application NDA213976 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)